Targeting fetal hemoglobin expression to treat β hemoglobinopathies

MH Steinberg - Expert Opinion on Therapeutic Targets, 2022 - Taylor & Francis
Introduction Sickle cell disease and β thalassemia are the principal β hemoglobinopathies.
The complex pathophysiology of sickle cell disease is initiated by sickle hemoglobin …